These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34583923)

  • 1. Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis.
    Adriawan IR; Atschekzei F; Dittrich-Breiholz O; Garantziotis P; Hirsch S; Risser LM; Kosanke M; Schmidt RE; Witte T; Sogkas G
    Ann Rheum Dis; 2022 Jan; 81(1):124-131. PubMed ID: 34583923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
    Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
    Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding CD4
    Estupiñán-Moreno E; Hernández-Rodríguez J; Li T; Ciudad L; Andrés-León E; Terron-Camero LC; Prieto-González S; Espígol-Frigolé G; Cid MC; Márquez A; Martin J; Ballestar E; Ortiz-Fernández L
    J Autoimmun; 2024 Jun; 146():103240. PubMed ID: 38754238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4
    Carmona EG; Callejas-Rubio JL; Raya E; Ríos-Fernández R; Villanueva-Martín G; Cid MC; Hernández-Rodríguez J; Ballestar E; Timmermann B; Ortego-Centeno N; Martín J; Márquez A
    J Autoimmun; 2024 Jan; 142():103124. PubMed ID: 37952293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
    Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
    Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.
    Bolha L; Hočevar A; Suljič A; Jurčić V
    Front Immunol; 2021; 12():791099. PubMed ID: 35003111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
    Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
    Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
    Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
    J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific Follicular Helper T Cell Signature in Takayasu Arteritis.
    Desbois AC; Régnier P; Quiniou V; Lejoncour A; Maciejewski-Duval A; Comarmond C; Vallet H; Rosenzwag M; Darrasse-Jèze G; Derian N; Pouchot J; Samson M; Bienvenu B; Fouret P; Koskas F; Garrido M; Sène D; Bruneval P; Cacoub P; Klatzmann D; Saadoun D
    Arthritis Rheumatol; 2021 Jul; 73(7):1233-1243. PubMed ID: 33538119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis.
    De Smit E; Lukowski SW; Anderson L; Senabouth A; Dauyey K; Song S; Wyse B; Wheeler L; Chen CY; Cao K; Wong Ten Yuen A; Shuey N; Clarke L; Lopez Sanchez I; Hung SSC; Pébay A; Mackey DA; Brown MA; Hewitt AW; Powell JE
    BMC Med Genomics; 2018 Jul; 11(1):61. PubMed ID: 30037347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon signature in giant cell arteritis aortitis.
    Vieira M; Régnier P; Maciejewski-Duval A; Le Joncour A; Darasse-Jèze G; Rosenzwajg M; Klatzmann D; Cacoub P; Saadoun D
    J Autoimmun; 2022 Feb; 127():102796. PubMed ID: 35123212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Giant Cell Arteritis.
    Guevara M; Kollipara CS
    Curr Rheumatol Rep; 2018 Apr; 20(5):25. PubMed ID: 29611005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.
    Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH
    Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells and systemic vasculitis.
    Mirouse A; Cacoub P; Saadoun D
    Curr Opin Rheumatol; 2023 Jan; 35(1):25-30. PubMed ID: 36508306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.